Leonard Khiroug, CSO of Neurotar, presents as part of the panel discussion on Strategies for CNS Drug and Device Development.
Neurotech Summit comes to Helsinki for the second time in 2013. This established US event for companies active in the field of neuroscience was successfully launched in Europe in 2011. It is a must for all companies active in the CNS and looking to extend their partner and investor networks. Follow this link to the event’s website: http://www.regonline.com/builder/site/default.aspx?EventID=1151412